Viridian Therapeutics, Inc. (VRDN) Reports In-Line Q2 EPS

Go back to Viridian Therapeutics, Inc. (VRDN) Reports In-Line Q2 EPS
(NASDAQ: VRDN) Delayed: 22.08 +0.09 (0.41%)
Previous Close $21.99    52 Week High
Open $22.00    52 Week Low
Day High $22.23    P/E N/A 
Day Low $21.62    EPS
Volume 1,093,388